Johnson & Johnson JNJ
$276.22 +$3.90 (+1.43%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $276.00 -0.08%
Open$267.56
Prev close$272.32
Day range$265.55 – $276.41
Volume8.86M
Market cap$664.95B
P/E (TTM)42.0
Dividend yield1.91%
JNJ Stock News
Headlines matching Johnson & Johnson or the JNJ ticker, most recent first.
- Johnson & Johnson(JNJ.US) Officer Sells US$9.23 Million in Common Stock
- UBS Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $320
- Apollo Global Management (APO.US) is reportedly in talks to acquire Johnson & Johnson's (JNJ.US) orthopedics business, with the potential deal valued at nearly $20 billion.
- Scotiabank Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $305
- BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $278 Positive
- J.P. Morgan Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $285 Positive
- Scotiabank Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $305
- Johnson & Johnson (JNJ.US) seeks priority review in China for talquetotab, a therapy aimed at inhibiting tumor formation and growth. Positive
- UBS Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $320
- UBS Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $320
- RBC Capital Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $287
- TD Cowen Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $300
- DBS Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $270 Positive
- RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $287
- Guggenheim Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $287 Positive
No comments yet — be the first to weigh in on JNJ.
Sign in to join the discussion.